Unitree Prices, China’s Robots Go Public, and the Supply Chain Behind the Headline Number

Unitree Robotics closed book-building on its STAR Market IPO today, with a final price due tomorrow and an implied valuation above ¥40 billion (~$5.9B). That number alone won’t move global portfolios. What it signals about China’s embodied-AI supply chain — sourcing, margins, capacity, and the state’s willingness to fast-track capital to the sector — is the actual story for anyone positioning around Physical AI.

Why This Isn’t the CXMT Trade

Comparisons to CXMT’s ~470-530% first-day surge are the wrong frame. CXMT listed with roughly 7% free float against a national-champion narrative in a chip category the West still dominates — a supply squeeze on top of a strategic story. Unitree’s float and raise are an order of magnitude smaller, and robotics is a less capital-intensive, less geopolitically singular category than advanced DRAM. Expect a meaningful pop on sentiment, not a repeat of a structural short squeeze.

The Supply Chain Read-Through

1. A “Unitree Effect” Is Already Repricing Suppliers

Pre-IPO investors and component suppliers have already seen their equity move on Unitree-adjacency alone. That’s the first tell: the market is pricing the ecosystem, not just the company. Watch for continued re-rating in actuator, motor, and sensor names with disclosed Unitree ties as the listing settles.

2. Localization Is the Moat, and the Margin

With roughly 90% of its supply chain sourced domestically, Unitree reports self-developed joint motors at 30-40% of the cost of comparable Western components, feeding into a reported 60% gross margin on the humanoid line. That’s the number that should matter most to a global investor: this is not a subsidized demo product, it’s a cost-structure argument for why Chinese humanoid hardware can undercut Western peers at scale — the same playbook that played out in EVs and solar.

3. Capacity Is About to Step-Change

A large share of IPO proceeds (~¥624M) is earmarked for a new manufacturing base targeting 75,000 humanoid and 115,000 quadruped units annually. That capacity target forces upstream suppliers — actuators, reducers, sensors, batteries — to scale in parallel or become the bottleneck. This is the layer where second-order investment ideas live.

Competitive Landscape: Who Else to Track

Below the top tier sit Leju Robotics (IPO-filed), EngineAI, and Fourier, part of a field of 140+ manufacturers and 330+ models introduced in 2025 — a market still sorting itself out, with Xiaomi and XPeng also active at the corporate-entrant level.

What Matters for Positioning in China

• Commercialization over concept: the market is rotating from narrative-driven investment toward companies proving repeat orders, real deployment, and gross margin — Unitree’s profitability is the differentiator versus cash-burning peers.
• Manufacturing dominance: China accounted for 84.7% of global humanoid shipments in 2025 and remains a net exporter of industrial robots, backed by a full-stack domestic ecosystem.
• Policy tailwind: Beijing is treating embodied AI as a strategic priority — subsidies, favorable lending, and a fast-tracked IPO approval for Unitree all point the same direction. Foreign capital, including Gulf sovereign funds and Korean conglomerates, is already positioning.
• Geopolitical overhang: the recent US ban on new imports of foreign-made humanoid and quadruped robots closes Unitree’s largest addressable Western market just as it goes public — domestic demand and non-US export markets now have to carry the growth case.

Ticker Watch

Unitree (STAR Market, pending) AgiBot / Zhiyuan (pre-IPO) UBTECH (HK-listed) DeepRobotics (STAR Market, filed)